Disruptive Pharma AB (OSTO:DPHA) Operating Margin %: % (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:DPHA Disruptive Pharma AB OSTO:DPHA
4 GF Score
Price kr1.21
View Full Analysis

What is Disruptive Pharma AB Operating Margin %?

Disruptive Pharma AB OSTO:DPHA +0.83% 4 Operating Margin % is % as of Jun. 2026. GuruFocus rates OSTO:DPHA with a GF Score™ of 4/100. Among 961 Drug Manufacturers companies, Disruptive Pharma AB ranks worse than 97.71% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Disruptive Pharma AB's Operating Income for the three months ended in Jun. 2026 was kr-4.50 Mil. Disruptive Pharma AB's Revenue for the three months ended in Jun. 2026 was kr0.00 Mil. Therefore, Disruptive Pharma AB's Operating Margin % for the quarter that ended in Jun. 2026 was %.

The historical rank and industry rank for Disruptive Pharma AB's Operating Margin % or its related term are showing as below:

OSTO:DPHA' s Operating Margin % Range Over the Past 10 Years
Min: -2291.68   Med: -2291.68   Max: -2291.68
Current: -2291.68


OSTO:DPHA's Operating Margin % is ranked worse than
97.71% of 961 companies
in the Drug Manufacturers industry
Industry Median: 7.24 vs OSTO:DPHA: -2291.68

Disruptive Pharma AB's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Disruptive Pharma AB's Operating Income for the three months ended in Jun. 2026 was kr-4.50 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was kr-52.92 Mil.


Disruptive Pharma AB  (OSTO:DPHA) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Disruptive Pharma AB Operating Margin % Related Terms


Disruptive Pharma AB Operating Margin % Historical Data

* Premium members only.

The historical data trend for Disruptive Pharma AB's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Disruptive Pharma AB Operating Margin % Chart

Disruptive Pharma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Disruptive Pharma AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OSTO:DPHA vs : Operating Margin % Comparison

For the Drug Manufacturers - General subindustry, Disruptive Pharma AB's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Disruptive Pharma AB Operating Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Disruptive Pharma AB's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Disruptive Pharma AB's Operating Margin % falls into.


OSTO:DPHA
4GF Score
Disruptive Pharma AB OSTO:DPHA
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Disruptive Pharma AB Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Disruptive Pharma AB's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-107.736 / 0
= %

Disruptive Pharma AB's Operating Margin % for the quarter that ended in Jun. 2026 is calculated as

Operating Margin %=Operating Income (Q: Jun. 2026 ) / Revenue (Q: Jun. 2026 )
=-4.495 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of % mean?
Disruptive Pharma AB (OSTO:DPHA) has a Operating Margin % of % as of Jun. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Disruptive Pharma AB and its competitors. According to the industry distribution chart, Disruptive Pharma AB ranks #939 out of 961 companies in the Drug Manufacturers industry, placing it in the top 97.7%.
Is Disruptive Pharma AB's Operating Margin % too high?
Disruptive Pharma AB's current Operating Margin % is %. Based on the distribution chart, Disruptive Pharma AB ranks #939 out of 961 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Disruptive Pharma AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Disruptive Pharma AB's Operating Margin % compare to ?
According to the Drug Manufacturers industry distribution chart, Disruptive Pharma AB ranks #939 out of 961 companies for Operating Margin %. This places Disruptive Pharma AB in the lower half of its industry. The industry median Operating Margin % is 7.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.24, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Disruptive Pharma AB and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Disruptive Pharma AB's current Operating Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Disruptive Pharma AB stock overvalued right now?
Disruptive Pharma AB (OSTO:DPHA) has a current Operating Margin % of %. The current Operating Margin % is %. Disruptive Pharma AB's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Disruptive Pharma AB (OSTO:DPHA), the current Operating Margin % is % as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Disruptive Pharma AB Business Description

Comparable Companies
Address Dag Hammarskjold Road 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Disruptive Pharma AB is a Swedish drug delivery technology company developing and commercializing Formulite, a patented platform based on mesoporous magnesium carbonate (MMC). The platform is designed to improve the solubility, oral bioavailability and other properties of pharmaceutical compounds. The company's business model is based on contract development, partnerships and licensing arrangements with pharmaceutical and biotechnology companies for the development and commercialization of drug products optimized with Formulite.
4GF Score

Get the complete analysis for OSTO:DPHA

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.21
Price